569351-62-8

Basic information

• Product Name: 1'-Oxo-spiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxylic acid
• Synonyms: 1''-OXO-SPIRO[CYCLOHEXANE-1,3''(1''H)-FURO[3,4-C]PYRIDINE]-4-CARBOXYLIC ACID
• CAS NO: 569351-62-8
• Molecular Formula: C₁₃H₁₃NO₄
• Molecular Weight: 247.249
• Mol File: 569351-62-8.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Density: 1.41
• CAS DataBase Reference: 1'-Oxo-spiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1'-Oxo-spiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxylic acid(569351-62-8)
• EPA Substance Registry System: 1'-Oxo-spiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxylic acid(569351-62-8)

Safety Data

• Hazardous Substances Data: 569351-62-8(Hazardous Substances Data)

Usage

General Description

1'-Oxo-spiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxylic acid is a chemical compound with a complex structure. It is a spirocyclic compound with a cyclohexane ring fused to a furo[3,4-c]pyridine ring, and a carboxylic acid group attached to the spiro carbon. 1'-Oxo-spiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxylic acid may have potential biological activity due to its unique structure, making it of interest for pharmaceutical research. Additionally, it may also have uses in organic synthesis and material science due to its complex and versatile structure. However, further research and testing are needed to fully understand the properties and potential applications of this compound.

Downstream Products

• 807320-43-0 1'-oxospiro[1,3'-cyclohexane(1'H)-furo[3,4-c]pyridine]-4-carboxylic acid 
• 328233-23-4 trans-1'-oxospiro[1,3'-cyclohexane(1'H)-furo[3,4-c]pyridine]-4-carboxylic acid 
• 328232-95-7 MK-0557 

Relevant articles and documents

Spiro compounds

Compounds of the general formula (I): wherein Ar1represents optionally substituted aryl or heteroaryl; n represents 0 or 1; T, U, V, and W each independently represent nitrogen atom or optionally substituted methine group, where at least two of them represent the said methine group; X represents methine or hydroxy substituted methine; Y represents an optionally substituted imino or oxygen atom are described and claimed. These novel spiro compounds are useful as neuropeptide Y receptor antagonists and as agents for the treatment of various kinds of cardiovascular disorders, central nervous system disorders, metabolic diseases and the like.

Novel spiro compounds

Compounds of the general formula (I): wherein Ar1 represents optionally substituted aryl or heteroaryl; n represents 0 or 1; T, U, V, and W each independently represent nitrogen atom or optionally substituted methine group, where at least two of them represent the said methine group; X represents methine or hydroxy substituted methine; Y represents an optionally substituted imino or oxygen atom are described and claimed. These novel spiro compounds are useful as neuropeptide Y receptor antagonists and as agents for the treatment of various kinds of cardiovascular disorders, central nervous system disorders, metabolic diseases and the like.